- Tytuł:
- Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain
- Autorzy:
- Temat:
-
cost-effectiveness
gemtuzumab ozogamicin
acute myeloid leukaemia
spain
Medicine (General)
R5-920
Therapeutics. Pharmacology
RM1-950 - Źródło:
- ClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 263-277 (2021)
- Opis pliku:
- electronic resource
- Relacje:
- https://www.dovepress.com/cost-effectiveness-analysis-of-gemtuzumab-ozogamicin-for-first-line-tr-peer-reviewed-fulltext-article-CEOR; https://doaj.org/toc/1178-6981
- Dostęp URL:
- https://doaj.org/article/e8d13246c5bb4958b110035d96a427b0  Link otwiera się w nowym oknie
Czasopismo naukowe